Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule

NCT00289744 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

178

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B
Hepatitis A

Interventions

BIOLOGICAL: TWINRIX™ ADULT
BIOLOGICAL: Engerix TM

Sponsor

GlaxoSmithKline